Li, Ting
Liu, Yan-ping
Liu, Shu-qin
Shi, Ping
Jiang, Xin
Tao, Ye
Gao, Xiao-meng
Ma, Ya-ping
Cao, Yu
Funding for this research was provided by:
National Major Scientific and Technological Special Project for “Significant New Drugs Development” (2020ZX09201-018, 2017ZX09304-024)
Natural science foundation of Shandong province (ZR2019MH101)
Article History
Received: 5 January 2022
Accepted: 4 July 2022
First Online: 7 July 2022
Declarations
:
: The authors declare no competing interests.
: All experimental documents, including protocol, informed consent and drug inspection report were approved by the Medical Ethics Committee of the Affiliated Hospital of Qingdao University on August 01, 2018 (No.: QYFYEC 2018–055–01). The study was carried out in accordance with relevant guidelines and regulations. Written informed consent was obtained from all subjects before their participation in the study.
: Not applicable in the declarations section.